Free Shipping on Orders of $50 or more.

Mergers and Acquisitions in the Global Pharmaceutical Industry - Paperback

Mergers and Acquisitions in the Global Pharmaceutical Industry - Paperback

Regular price $34.43
Sale price $34.43 Regular price
Sale Sold out
Unit price
/per 
This is a pre order item. We will ship it when it comes in stock.
Lock Secure Transaction

by Mennen (Author), Abayomi (Author), Jian (Author)

Project Report from the year 2006 in the subject Communications - Public Relations, Advertising, Marketing, Social Media, grade: 65 % - B, University of Sunderland, course: Global Corporate Strategy, language: English, abstract: Mergers and acquisitions are of major importance in the pharmaceutical industry. In order to evaluate the dynamics of this particular industry, this paper critically evaluates the pre- and post- merger situation of GlaxoSmithKline concerning its ready-access to markets, know-how and management capability. Furthermore, strengths and weaknesses and merger's outcomes will be outlined. Critical push and pull factors affecting M&A activity in North America will be analysed, using Pfizer and Pharmacia as an example. In addition, general reasons for M&A failure in the pharmaceutical industry will be illustrated focussing on the M&A activity of GlaxoSmithKline. Finally, using two global pharmaceutical players (GSK and Astrazeneca), the merits and demerits of the McKinsey's five step programme will be discussed.

Number of Pages: 64
Dimensions: 0.15 x 8.27 x 5.83 IN
Publication Date: August 09, 2013